Carlos Hernández

8PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsFood properties (incl. characteristics and health benefits)Predictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 02, 2021
A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets.

Ester Blanco, Maria Ibañez-Vea, Carlos Hernandez

|Aug 09, 2020
Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition.

Hugo Arasanz, Carlos Hernández, Ana Bocanegra

|Apr 05, 2020
Diminished Vitamin D Receptor Protein Levels in Crohn's Disease Fibroblasts: Effects of Vitamin D.

Laura Gisbert-Ferrándiz, Jesús Cosín-Roger, Carlos Hernández

|Apr 05, 2020
Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies.

Carlos Hernandez, Hugo Arasanz, Luisa Chocarro

|Apr 17, 2019
PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer.

Ana Bocanegra, Gonzalo Fernandez-Hinojal, Miren Zuazo-Ibarra

|Feb 28, 2018
Indomethacin Disrupts Autophagic Flux by Inducing Lysosomal Dysfunction in Gastric Cancer Cells and Increases Their Sensitivity to Cytotoxic Drugs.

Jorge Vallecillo-Hernández, Maria Dolores Barrachina, Dolores Ortiz-Masiá

Pageof 2